Episodes of (Dis)Connected Consciousness in ICU Survivors
NCT ID: NCT07048951
Last Updated: 2025-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2025-04-01
2027-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incidence of Episodes of (Dis)Connected Consciousness Among Emergency Patients Admitted in the Resuscitation Room
NCT06362525
Predictive Outcome in Comatose Patients
NCT05321459
Electrophysiological Signatures of Cognitive Disorders Related to Intensive Care Unit (ICU) delirium_ BRAINSTORM-EEG
NCT06089538
Patients Visit Prior to Hospital Admission & Intensive Care Unit
NCT03605407
WHO Covid 19 - Neurological Abnormalities in SARS-CoV-2 ICU Patients
NCT04643548
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Survivors of prolonged ICU (≥7days) stay with episode(s) of pharmacological/non-pharmacological coma
The Near-Death Experience Content (NDE-C) scale
Questionnaire to detect occurence of NDE. A NDE is identified if score \> or = 27/80
Threat perception measure
7 items scale investigating the participant's psychological vulnerability during their stay at the ICU
Interview about the participant's memories of the ICU
Participants will be asked to describe any dream, hallucination, or any other unusual experience they can recall from their stay at the ICU.
Additionally, the participants will be asked to describe any memory they have of the environment of the ICU, such as the appearance of the room, medical staff, family visiting, noises, etc.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The Near-Death Experience Content (NDE-C) scale
Questionnaire to detect occurence of NDE. A NDE is identified if score \> or = 27/80
Threat perception measure
7 items scale investigating the participant's psychological vulnerability during their stay at the ICU
Interview about the participant's memories of the ICU
Participants will be asked to describe any dream, hallucination, or any other unusual experience they can recall from their stay at the ICU.
Additionally, the participants will be asked to describe any memory they have of the environment of the ICU, such as the appearance of the room, medical staff, family visiting, noises, etc.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Experienced a pharmacological or non-pharmacological episode of loss of consciousness
* French speaking
Exclusion Criteria
* Chronic disorder of consciousness
* Confusion or delirium
* Deafness
* Blindness
* Aphasia
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Liege
OTHER
University of Liege
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU of Liège
Liège, Liège, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-254
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.